Median Diagnostics Inc
233250
Company Profile
Business description
Median Diagnostics Inc is a Korea based company engaged in the human and animal disease diagnosis business, which falls within the in vitro diagnostics industry. In vitro diagnostic kits are defined as medical devices, reagents, calibrators, specimen containers, and other items that provide information for diagnosing, monitoring, or assessing the suitability of patients or animals by testing specimens such as tissue, blood, or urine in vitro.
Contact
878 Sunhwan-daero
Dongnae-myeon
Gangwon-do
Chuncheon-si200-883
KORT: +82 332440100
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
67
Stocks News & Analysis
stocks
Chart of the Week: Recent selloffs in this ASX sector opens doors to opportunity
Ongoing rate hikes have investors spooked.
stocks
ASX dividend champions: Stocks, ETFs and LICs
Mark and Shani run through lessons for ASX stocks, ETFs and LICs that have delivered over the past decade.
stocks
SpaceX’s IPO filing: Big spending, big losses
The first public financials from Elon Musk’s company highlight Starlink’s revenue power and increased spending on AI.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,854.50 | 4.20 | 0.05% |
| CAC 40 | 8,117.42 | 135.66 | 1.70% |
| DAX 40 | 24,737.24 | 336.59 | 1.38% |
| Dow JONES (US) | 50,009.35 | 645.47 | 1.31% |
| FTSE 100 | 10,432.34 | 101.79 | 0.99% |
| HKSE | 25,644.86 | 6.26 | -0.02% |
| NASDAQ | 26,270.36 | 399.65 | 1.54% |
| Nikkei 225 | 61,885.58 | 2,081.17 | 3.48% |
| NZX 50 Index | 12,846.44 | 85.41 | 0.67% |
| S&P 500 | 7,432.97 | 79.36 | 1.08% |
| S&P/ASX 200 | 8,631.80 | 3.80 | 0.04% |
| SSE Composite Index | 4,162.37 | 0.19 | 0.00% |